Meridian won the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site and Best Clinical Trial Network.
The winners were announced at the virtual World Vaccine Congress. The awards were decided by two rounds of voting and a scientific advisory board. Judges reviewed performance metrics, diversity of capabilities for vaccine trials, ongoing outcomes, and other factors to select a winner.
OMAHA, Neb. (PRWEB)
October 01, 2020
Meridian Clinical Research, a leading investigative research network, won the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site. Meridian is also the largest member of Platinum Research Network, which won the ViE award for Best Clinical Trial Network.
“It’s incredible to earn these awards when vaccine trials are the industry’s priority and so visible in the public spotlight,” said Nicole Osborn, Meridian founder and CEO. “It reaffirms the quality of work our investigators and staff put forward every day, and the trust we’ve established with leading vaccine developers.”
The winners were announced at the virtual World Vaccine Congress typically held in Washington. The awards were decided by two rounds of voting and a final judgement by a scientific advisory board. Judges reviewed performance metrics, diversity of capabilities for vaccine trials, ongoing outcomes, and other factors to select a winner.
“In the past few years, we focused on providing fast startup, immediate enrollment, and scalability for our clients’ vaccine research programs,” said Osborn. “When COVID-19 vaccine trials began, we had the capabilities and reach when Sponsors and CROs needed it most.”
Earlier this year, Meridian principal investigators were the first in the U.S. to enroll patients into Phase II and III COVID-19 vaccine studies. Leaders of the Operation Warp Speed (OWS) program — including Moncef Slaoui, chief advisor, and General Gustave F. Perna, chief operating officer — visited Meridian’s internal medicine site in Savannah, GA.
A longtime leader in vaccine research, Meridian is conducting COVID-19 vaccine clinical trials at nine of its 23 sites.
Sponsors and CROs interested in partnering with Meridian should email Andrew Kimball, VP, business development, at akimball@mcrmed.com.
***
About Meridian Clinical Research
Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is a multi-specialty site network headquartered at its dedicated research center in Omaha, NE, and conducts Phase I-IV studies at investigative sites across North America. Meridian supports research across numerous therapeutic areas and specializes in high-volume vaccine trials.
Share article on social media or email: